These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 18777592)

  • 1. Mucosal cytokine network in inflammatory bowel disease.
    Andoh A; Yagi Y; Shioya M; Nishida A; Tsujikawa T; Fujiyama Y
    World J Gastroenterol; 2008 Sep; 14(33):5154-61. PubMed ID: 18777592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic therapy for inflammatory bowel disease.
    Ardizzone S; Bianchi Porro G
    Drugs; 2005; 65(16):2253-86. PubMed ID: 16266194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of mucosal dendritic cells in inflammatory bowel disease.
    Niess JH
    World J Gastroenterol; 2008 Sep; 14(33):5138-48. PubMed ID: 18777590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of disrupted intestinal barrier in inflammatory bowel diseases.
    Salim SY; Söderholm JD
    Inflamm Bowel Dis; 2011 Jan; 17(1):362-81. PubMed ID: 20725949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
    Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
    Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokines in inflammatory bowel disease.
    Rogler G; Andus T
    World J Surg; 1998 Apr; 22(4):382-9. PubMed ID: 9523521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine network in inflammatory bowel disease.
    Fuss IJ
    Curr Drug Targets Inflamm Allergy; 2003 Jun; 2(2):101-12. PubMed ID: 14561161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease.
    Shioya M; Nishida A; Yagi Y; Ogawa A; Tsujikawa T; Kim-Mitsuyama S; Takayanagi A; Shimizu N; Fujiyama Y; Andoh A
    Clin Exp Immunol; 2007 Sep; 149(3):480-6. PubMed ID: 17590175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cytokines in the pathogenesis of inflammatory bowel disease.
    Papadakis KA; Targan SR
    Annu Rev Med; 2000; 51():289-98. PubMed ID: 10774465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transducers and activators of transcription 3 signaling pathway: an essential mediator of inflammatory bowel disease and other forms of intestinal inflammation.
    Musso A; Dentelli P; Carlino A; Chiusa L; Repici A; Sturm A; Fiocchi C; Rizzetto M; Pegoraro L; Sategna-Guidetti C; Brizzi MF
    Inflamm Bowel Dis; 2005 Feb; 11(2):91-8. PubMed ID: 15677901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory bowel disease: clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogeneses?
    Brandtzaeg P
    Acta Odontol Scand; 2001 Aug; 59(4):235-43. PubMed ID: 11570527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inflammatory mediators in chronic inflammatory bowel diseases.
    Gross V; Andus T; Leser HG; Roth M; Schölmerich J
    Klin Wochenschr; 1991 Dec; 69(21-23):981-7. PubMed ID: 1798295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease.
    Reimund JM; Wittersheim C; Dumont S; Muller CD; Baumann R; Poindron P; Duclos B
    J Clin Immunol; 1996 May; 16(3):144-50. PubMed ID: 8734357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mend Your Fences: The Epithelial Barrier and its Relationship With Mucosal Immunity in Inflammatory Bowel Disease.
    Martini E; Krug SM; Siegmund B; Neurath MF; Becker C
    Cell Mol Gastroenterol Hepatol; 2017 Jul; 4(1):33-46. PubMed ID: 28560287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
    Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A potential role for regulatory T-cells in the amelioration of DSS induced colitis by dietary non-digestible polysaccharides.
    Hartog A; Belle FN; Bastiaans J; de Graaff P; Garssen J; Harthoorn LF; Vos AP
    J Nutr Biochem; 2015 Mar; 26(3):227-33. PubMed ID: 25498760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemokine and cytokine levels in inflammatory bowel disease patients.
    Singh UP; Singh NP; Murphy EA; Price RL; Fayad R; Nagarkatti M; Nagarkatti PS
    Cytokine; 2016 Jan; 77():44-9. PubMed ID: 26520877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biologic targeting in the treatment of inflammatory bowel diseases.
    Bosani M; Ardizzone S; Porro GB
    Biologics; 2009; 3():77-97. PubMed ID: 19707398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in cytokines: therapeutic implications for inflammatory bowel diseases.
    Bouguen G; Chevaux JB; Peyrin-Biroulet L
    World J Gastroenterol; 2011 Feb; 17(5):547-56. PubMed ID: 21350703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.